Evaluation of eight anti-rubella virus immunoglobulin G immunoassays that report results in international units per milliliter

Journal of Clinical Microbiology

Volumn 46, Issue 6, 2008, Pages 1955-1960

  Dimech, Wayne ^a,f   Panagiotopoulos, Lena ^a   Francis, Barbara ^a   Laven, Nicholas ^b   Marler, Joan ^b   Dickeson, David ^c   Panayotou, Tony ^d   Wilson, Kim ^a   Wootten, Robyn ^b   Dax, Elizabeth M ^a,e  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Dorevitch Pathology ^*  (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d Microbiology Department   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f National Serology Reference Laboratory   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANALYSIS OF VARIANCE; ARTICLE; CORRELATION ANALYSIS; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOASSAY; INTERNATIONAL STANDARD UNIT; POST HOC ANALYSIS; PRIORITY JOURNAL; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; REFERENCE STANDARDS; RUBELLA; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

RUBELLA VIRUS;

EID: 45149115947     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00231-08     Document Type: Article

References (32)

1. Anonymous. 1978. Haemagglutination-inhibition test for the detection of rubella antibody. J. Hyg. (London) 81:373-382.
2. Best, J. M. 2007. Rubella. Semin. Fetal Neonatal Med. 12:182-192.
3. Best, J. M., S. O'Shea, G. Tipples, N. Davies, S. M. Al-Khusaiby, A. Krause, L. M. Hesketh, L. Jin, and G. Enders. 2002. Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ 325:147-148.
4. Cradock-Watson, J. E. 1991. Laboratory diagnosis of rubella: past, present and future. Epidemiol. Infect. 107:1-15.
5. Crofts, N., W. Maskill, and I. D. Gust. 1988. Evaluation of enzyme-linked immunosorbent assays: a method of data analysis. J. Virol. Methods 22:51-59.
6. Dati, F. 2004. An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur immunoassay system. Clin. Lab. 50:53-61.
7. Dati, F., G. Denoyel, and J. van Helden. 2004. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. J. Clin. Virol. 30(Suppl. 1):S6-S10.
8. Diepersloot, R. J., H. Dunnewold-Hoekstra, J. Kruit-Den Hollander, and F. Vlaspolder. 2001. Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems. Clin. Diagn. Lab. Immunol. 8:785-787.
9. Dimech, W., A. Bettoli, D. Eckert, B. Francis, J. Hamblin, T. Kerr, C. Ryan, and I. Skurrie. 1992. Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter. J. Clin. Microbiol. 30:633-641.
10. Francis, B. H., L. I. Hatherley, J. E. Walstab, and L. I. Taft. 1982. Rubella screening and vaccination programme at a Melbourne maternity hospital. A five-year review. Med. J. Aust. 1:502-504.
11. Francis, B. H., A. K. Thomas, and C. A. McCarty. 2003. The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia. Am. J. Public Health 93:1274-1276.
12. Kleeman, K. T., D. J. Kiefer, and S. P. Halbert. 1983. Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera. J. Clin. Microbiol. 18:1131-1137.
13. Maroto Vela, M. C., M. C. Bernal Zamora, A. Levya Garcia, and G. Piedrola. 1986. Detection of specific IgG and IgM antibodies in the haemagglutination Inhibition test and the enzyme-linked immunoassay for the diagnosis of rubella infection. Infection 14:159-162.
14. Mitchell, L. A., M. K. Ho, J. E. Rogers, A. J. Tingle, R. G. Marusyk, J. M. Weber, P. Duclos, M. L. Tepper, M. Lacroix, and M. Zrein. 1996. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals. J. Clin. Microbiol. 34:2210-2218.
15. National Committee for Clinical Laboratory Standards. 1997. Detection and quantitation of rubella IgG antibody: evaluation and performance criteria for multiple component test products, specimen handling, and use of test products in the clinical laboratory; approved guideline. NCCLS guideline I/LA6-A, vol. 17, p.25. National Committee for Clinical Laboratory Standards, Villanova, PA.
16. Nedeljkovic, J., T. Jovanovic, S. Mladjenovic, K. Hedman, N. Peitsaro, and C. Oker-Blom. 1999. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells. J. Clin. Virol. 14:119-131.
17. Okrongly, D. 2004. The ADVIA Centaur immunoassay system - designed for infectious disease testing. J. Clin. Virol. 30(Suppl. 1):S19-S22.
18. O'Shea, S., J. M. Best, and J. E. Banatvala. 1983. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J. Infect. Dis. 148:639-647.
19. O'Shea, S., H. Dunn, S. Palmer, J. E. Banatvala, and J. M. Best. 1999. Automated rubella antibody screening: a cautionary tale. J. Med. Microbiol. 48:1047.
20. Owen, W. E., T. B. Martins, C. M. Litwin, and W. L. Roberts. 2006. Performance characteristics of six IMMULITE 2000 TORCH assays. Am. J. Clin. Pathol. 126:900-905.
21. Petersen, E., M. V. Borobio, E. Guy, O. Liesenfeld, V. Meroni, A. Naessens, E. Spranzi, and P. Thulliez. 2005. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii- specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43:1570-1574.
22. Plotkin, S. A. 2001. Rubella eradication. Vaccine 19:3311-3319.
23. Robertson, S. E., S. L. Cochi, G. A. Bunn, D. L. Morse, and S. R. Preblud. 1987. Preventing rubella: assessing missed opportunities for immunization. Am. J. Public Health 77:1347-1349.
24. Robertson, S. E., F. T. Cutts, R. Samuel, and J. L. Diaz-Ortega. 1997. Control of rubella and congenital rubella syndrome (CRS) on developing countries. Part 2. Vaccination against rubella. Bull. W. H. O. 75:69-80.
25. Robertson, S. E., D. A. Featherstone, M. Gacic-Dobo, and B. S. Hersh. 2003. Rubella and congenital rubella syndrome: global update. Rev. Panam Salud Publica 14:306-315.
26. Skendzel, L. P. 1996. Rubella immunity. Defining the level of protective antibody. Am. J. Clin. Pathol. 106:170-174.
27. Steece, R. S., M. S. Talley, M. R. Skeels, and G. A. Lanier. 1985. Comparison of enzyme-linked immunosorbent assay, hemagglutination inhibition, and passive latex agglutination for determination of rubella immune status. J. Clin. Microbiol. 21:140-142.
28. Steece, R. S., M. S. Talley, M. R. Skeels, and G. A. Lanier. 1984. Problems in determining immune status in borderline specimens in an enzyme immunoassay for rubella immunoglobulin G antibody. J. Clin. Microbiol. 19:923-925.
29. van Weemen, B., and J. Kacaki. 1976. A modified haemagglutination inhibition test for rubella antibodies, using standardized, freeze-dried reagents. Report of a comparative multi-centre trial. J. Hyg. (London) 77:31-42.
30. Vlaspolder, F., P. Singer, A. Smit, and R. J. Diepersloot. 2001. Comparison of Immulite with Vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands. Clin. Diagn. Lab. Immunol. 8:552-555.
31. Wilson, K. M., C. Di Camille, L. Doughty, and E. M. Dax. 2006. Humoral immune response to primary rubella virus infection. Clin. Vaccine Immunol. 13:380-386.
32. Zhang, T., C. A. Mauracher, L. A. Mitchell, and A. J. Tingle. 1992. Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. J. Clin. Microbiol. 30:824-830.